About Contact Us Careers
Sign In

Wilson Disease Drugs Market - Top Companies and Manufacturers

  • Report ID: 2863
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Companies Dominating the Wilson Disease Drugs Landscape

    • Merck & Co., Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bausch Health Companies Inc.
    • Alexion Pharmaceuticals, Inc.
    • Nobelpharma Co., Ltd.
    • Kodmon Holdings, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Tsumura & Co.
    • VHB Medi Sciences Limited
    • Pfizer Inc.
    • Lupin Limited
    • Vivet Therapeutics
    • NAVINTA LLC
Browse Key Market Insights with Data Illustration:

In the News

  • Alexion Pharmaceuticals, Inc. made an announcement regarding the acquisition of LogicBio Therapeutic, Inc. The acquisition took place to accelerate the growth of Alexion Pharmaceuticals in developing genomic medicines using the unique technology of LogicBio.

  • Kadmon Holdings, Inc. announced that its generic Trientine Hydrochloride Capsules USP, 250 mg, which is a chelating agent used for the treatment of Wilson’s disease in patients who are intolerant of penicillamine, has been approved by the U.S. Food and Drug Administration (FDA).


Author Credits:  Radhika Pawar


  • Report ID: 2863
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of wilson disease drugs is estimated at USD 697.71 million.

The wilson disease drugs market size was over USD 652.08 million in 2024 and is anticipated to cross USD 1.12 billion by 2037, witnessing more than 4.3% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of Wilson’s disease in the young population and increasing health spending across the globe will boost the market growth.

North America industry is poised to dominate majority revenue share of 30% by 2037, propelled by presence of leading market players in the region which manufacture and distribute Wilson disease drugs.

The major players in the market are Merck & Co., Inc., Bausch Health Companies Inc., Alexion Pharmaceuticals, Inc., Nobelpharma Co., Ltd., Kodmon Holdings, Inc., Teva Pharmaceutical Industries Ltd., Tsumura & Co., VHB Medi Sciences Limited, Pfizer Inc., Lupin Limited, Vivet Therapeutics, NAVINTA LLC
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample